Akston Biosciences Corporation (AXTN)

Akston Biosciences will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$8.00 - $10.00

Shares Offered

2,222,222

Deal Size

$20.00M

Akston Biosciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	6.97	16.49	5.11
Revenue Growth	-	222.32%	-
Gross Profit	0.23	3.04	3.25
Operating Income	-18.36	-14.84	-9.08
Net Income	1.39	3.81	-9.55

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	2.91	1.89	0.81
Total Debt	10.91	11.1	6.68
Net Cash (Debt)	-8	-9.21	-5.88
Net Cash Growth	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-15.08	-13.54	-4.4
Capital Expenditures	-0.94	-0.12	-0.75
Free Cash Flow	-16.03	-13.66	-5.15
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	3.34%	18.44%	63.53%
Operating Margin	-263.53%	-90.04%	-177.58%
Pretax Margin	21.53%	23.74%	-186.66%
Profit Margin	20.02%	23.10%	-186.66%
FCF Margin	-229.98%	-82.85%	-100.62%